文献速递头颈与中枢神经肿瘤

合成遗传示踪揭示胶质母细胞瘤与先天免疫细胞病理互作的表型图谱

Phenotypic Mapping of Pathologic Cross-Talk between Glioblastoma and Innate Immune Cells by Synthetic Genetic Tracing.
PubMed 文献 · Cancer Discov · 2020-12-23

该研究利用胶质母细胞瘤亚型特征构建合成遗传示踪盒,在体外和体内探究肿瘤异质性。研究发现 proneural 亚型是固定身份,而 mesenchymal 亚型是适应性的亚稳态,由促炎和分化信号及 DNA 损伤驱动,而非缺氧。先天免疫细胞可诱导 proneural 向 mesenchymal 转变,导致治疗抵抗。

要点

  • 合成遗传示踪可区分胶质母细胞瘤状态及命运转换。
  • mesenchymal 亚型由促炎、分化信号和 DNA 损伤驱动。
  • 先天免疫细胞驱动 proneural 向 mesenchymal 转变致治疗抵抗。

核心结论

  • proneural 胶质母细胞瘤是固定身份,mesenchymal 是适应性的亚稳态细胞状态。
  • 先天免疫细胞将胶质母细胞瘤细胞转向 proneural 向 mesenchymal 转变, confer 治疗抵抗。
  • 合成遗传示踪方法将微环境、遗传和药理扰动与 mesenchymal 承诺因果关联。

研究设计与样本

  • 利用胶质母细胞瘤亚型特征构建合成遗传示踪盒。
  • 在体外和体内研究肿瘤异质性。
  • 通过合成基因座控制区实现示踪。

主要发现

  • proneural 胶质母细胞瘤是 hardwired 身份,mesenchymal 是 adaptive 和 metastable 细胞状态。
  • mesenchymal 状态由促炎和分化信号及 DNA 损伤驱动,而非缺氧。
  • 先天免疫细胞将胶质母细胞瘤细胞转向 proneural-to-mesenchymal 转变, confer 治疗抵抗。

临床怎么用

  • 合成遗传示踪方法简单、可扩展,广泛适用于研究发育和疾病中的稳态。
  • 在胶质母细胞瘤中,该方法因果连接不同(微)环境、遗传和药理扰动与 mesenchymal 承诺。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Glioblastoma is a lethal brain tumor that exhibits heterogeneity and resistance to therapy. Our understanding of tumor homeostasis is limited by a lack of genetic tools to selectively identify tumor states and fate transitions. Here, we use glioblastoma subtype signatures to construct synthetic genetic tracing cassettes and investigate tumor heterogeneity at cellular and molecular levels, in vitro and in vivo. Through synthetic locus control regions, we demonstrate that proneural glioblastoma is a hardwired identity, whereas mesenchymal glioblastoma is an adaptive and metastable cell state driven by proinflammatory and differentiation cues and DNA damage, but not hypoxia. Importantly, we discovered that innate immune cells divert glioblastoma cells to a proneural-to-mesenchymal transition that confers therapeutic resistance. Our synthetic genetic tracing methodology is simple, scalable, and widely applicable to study homeostasis in development and diseases. In glioblastoma, the method causally links distinct (micro)environmental, genetic, and pharmacologic perturbations and mesenchymal commitment. SIGNIFICANCE: Glioblastoma is heterogeneous and incurable. Here, we designed synthetic reporters to reflect the transcriptional output of tumor cell states and signaling pathways' activity. This method is generally applicable to study homeostasis in normal tissues and diseases. In glioblastoma, synthetic genetic tracing causally connects cellular and molecular heterogeneity to therapeutic responses.This article is highlighted in the In This Issue feature, p. 521.

来源:Cancer Discov,查看原文。版权归原作者所有。

引用

  1. Schmitt MJ, Company C, Dramaretska Y, et al. Phenotypic Mapping of Pathologic Cross-Talk between Glioblastoma and Innate Immune Cells by Synthetic Genetic Tracing. Cancer Discov. 2020. PMID: 33361384. doi:10.1158/2159-8290.CD-20-0219

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。